10x Genomics, Inc. is trading 3.6% up today at $30.23, staging a modest recovery following last week's sharp technology-led sell-off.
- Shareholders approved all proposals at the June 4, 2026, annual meeting, including director elections and auditor ratification, which has removed a lingering governance overhang.
- The stock is rebounding alongside improved risk sentiment in broader U.S. equities, with no fresh company-specific news reported this morning.
- The move marks a stabilization for the life sciences firm as market volatility in the tech sector begins to subside.